Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.87 USD
Change Today -0.165 / -1.50%
Volume 1.2M
MDXG On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

mimedx group inc (MDXG) Snapshot

Open
$11.02
Previous Close
$11.04
Day High
$11.12
Day Low
$10.68
52 Week High
12/22/14 - $11.97
52 Week Low
07/28/14 - $6.10
Market Cap
1.2B
Average Volume 10 Days
3.0M
EPS TTM
$0.10
Shares Outstanding
108.6M
EX-Date
--
P/E TM
108.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for MIMEDX GROUP INC (MDXG)

Related News

No related news articles were found.

mimedx group inc (MDXG) Related Businessweek News

No Related Businessweek News Found

mimedx group inc (MDXG) Details

MiMedx Group, Inc. develops, processes, and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies are AmnioFix, EpiFix, and CollaFix. The company’s AmnioFix and EpiFix are tissue technologies processed from human amniotic membrane derived from donated placentas. Through its donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. The company processes the human amniotic membrane utilizing its proprietary PURION Process to produce a safe and effective implant. Its CollaFix technology platform is a collagen fiber technology, developed with its patented cross-linking polymers, designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues in order to augment their repair. MiMedx Group supplies approximately 400,000 allografts for application in the wound care, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare through direct sales force, independent sales representatives, and distributors, as well as through private label or OEM relationships. The company was incorporated in 2008 and is headquartered in Marietta, Georgia.

386 Employees
Last Reported Date: 03/13/15
Founded in 2008

mimedx group inc (MDXG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $914.9K
President, Chief Operating Officer and Direct...
Total Annual Compensation: $422.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $295.0K
Compensation as of Fiscal Year 2014.

mimedx group inc (MDXG) Key Developments

MiMedx Group, Inc.(NasdaqCM:MDXG) added to S&P 1000 Index

MiMedx Group, Inc.(NasdaqCM:MDXG) added to S&P 1000 Index

MiMedx Group, Inc.(NasdaqCM:MDXG) added to S&P SmallCap 600 Index

MiMedx Group, Inc.(NasdaqCM:MDXG) added to S&P SmallCap 600 Index

MiMedx Group, Inc.(NasdaqCM:MDXG) added to S&P SmallCap 600 Sector Indices – Health Care Sector Index

MiMedx Group, Inc.(NasdaqCM:MDXG) added to S&P SmallCap 600 Sector Indices – Health Care Sector Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDXG:US $10.87 USD -0.165

MDXG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliqua BioMedical Inc $5.42 USD +0.07
Derma Sciences Inc $7.01 USD -0.06
Medtronic PLC $73.81 USD -0.27
Osiris Therapeutics Inc $19.27 USD -0.29
Smith & Nephew PLC 1,084 GBp -6.00
View Industry Companies
 

Industry Analysis

MDXG

Industry Average

Valuation MDXG Industry Range
Price/Earnings 100.0x
Price/Sales 8.2x
Price/Book 13.6x
Price/Cash Flow 97.1x
TEV/Sales 8.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIMEDX GROUP INC, please visit www.mimedx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.